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Background: Patients with terminal cancer frequently suffer from sleep sweats, which occur while
sleeping and cease after waking; the cause of these sweats is unknown. The aim of this study was to
evaluate the efﬁcacy of a modiﬁed Dang Gui Liu Huang Tang in managing sleep sweats, as well as to
identify any associated adverse effects.
Methods: We enrolled 41 patients with terminal cancer who were receiving hospice care. We excluded
patients whose sweating had known causes, as well as those taking drugs that can affect the sweating
threshold. Patients received a modiﬁed Dang Gui Liu Huang Tang twice a day for 10 consecutive days.
Results: The quantitative assessment revealed that sleep sweating was completely relieved in 29 (70.7%)
patients, and that the average time required for a 50% decrease in sweating was 5.3 days. Using a visual
analog sweating scale that ranged from 0 to 10, patients and caregivers estimated that the mean decrease
in sweating was 7.6 and 8.0, respectively. Furthermore, 78.0% of patients experienced an increased
appetite after treatment. The most common adverse events were diarrhea (14.6%), nausea (12.1%), and
allergy (2.4%), although the severity of these symptoms was never greater than Grade 2, and they
resolved after the treatment was stopped.
Conclusion: The results suggest that the modiﬁed Dang Gui Liu Huang Tang is safe and effective in
treating sleep sweats of an unknown cause in elderly patients with terminal cancer.
Copyright © 2016, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Traditional herbal medicine is widely accepted and commonly
used by Asians because of its safety, natural origin, and fewer
adverse effects. Epidemiological surveys have shown that 44.6% ofre that they have no conﬂicts
tment of Radiation Oncology,
Road, Section 2, Taipei 104,
are Center, Mackay Memorial
104, Taiwan.
.-L. Lai), chenmdphd@gmail.
atric Emergency & Critical Care M
censes/by-nc-nd/4.0/).patients with cancer in Japan, and 31.4% in the USA, took comple-
mentary medicine during or after major cancer treatments1,2.
Cancer is the leading cause of death in many countries; at its
terminal stage, patients suffer from various complications, which
often develop simultaneously3e5. The majority of these complica-
tions can be alleviated or eased using palliative medicines. How-
ever, several troublesome symptoms have no speciﬁc and effective
treatment; sweating is one such symptom. Patients with terminal
cancer often suffer from frequent sweating of unknown cause. For
example, sleep sweats, which are characterized by sweating that
develops while sleeping and ceases after waking, are particularly
common in immunocompromised cancer patients. Such sweats
usually render patients more susceptible to upper airway infections
and resulting sepsis.edicine. Published by Elsevier Taiwan LLC. This is an open access article under the
Modiﬁed Dang Gui Liu Huang Tang and Sleep Sweats 97In traditional Chinese medicine (TCM), several effective herbal
prescriptions are available for treating sleep sweats; these pre-
scriptions are based on the different treatment principles used in
TCM. The most commonly prescribed herbal medication for sleep
sweats is Dang Gui Liu Huang Tang. This decoction functions to
nourish “Yin”, clear heat, and stabilize the exterior while stopping
sweating. Some other symptoms that indicate Dang Gui Liu Huang
Tang are fever, red face, dry mouth, dry parched lips, irritability,
dry stools, constipation, and scanty dark urine. In addition, as
conﬁrmed by clinical observations, Fu Xiao Mai (Tritici levis fruc-
tus) and Mu Li (Ostreae concha) are also widely used to treat
sweating. Therefore, we combined these two herbal drugs with
Dang Gui Liu Huang Tang to form a modiﬁed prescription; we then
evaluated the prescription’s effectiveness. To our knowledge, no
clinical evidence supports the use of this modiﬁed regimen to
treat sleep sweats.
In the present study, we evaluated the efﬁcacy of our modiﬁed
Dang Gui Liu Huang Tang in treating sleep sweats, as well as the
adverse events associated with the treatment. The study involved
patients with terminal cancer who were receiving palliative care in
a medical center-based hospice ward.2. Materials and methods
2.1. Participants
Between January 2000 and February 2003, 41 biopsy-conﬁrmed
patients with cancer who were suffering from sleep sweats were
enrolled in this prospective study. The other eligibility criteria were
age> 60 years, ability to tolerate oral or nasogastric tube feeding,
and receipt of palliative care in a medical center-based hospice
ward. The exclusion criteria were as follows: fever> 37.5C (aural),
hypoglycemia, use of drugs that can affect the sweating tempera-
ture threshold (clonidine, pilocarpine, physostigmine, atropine,
scopolamine, tramadol, or oral contraceptives), and bowel
obstruction. The study was approved by the Institutional Review
Board of the Mackay Memorial Hospital, Taipei, Taiwan (IRB
Number: 13MMHIS050), and informed consent was obtained from
all study participants.Table 1
Characteristics of the study patients.
Characteristic No. (%)
Sex
Male 20 (48.8)
Female 21 (51.2)
Age (y), mean ± SD 69.0± 6.4
Male 67.0± 5.8
Female 71.0± 6.5
Primary site of tumor
Head and neck 6 (14.6)
Lung 6 (14.6)
Breast 5 (12.2)
Cervical 5 (12.2)
Colon and rectal 4 (9.8)
Ovarian 3 (7.3)
Prostate 3 (7.3)
Liver 2 (4.9)
Endometrial 2 (4.9)
Esophagus 1 (2.4)
Gall bladder 1 (2.4)
Ureter 1 (2.4)
Lymphocyte 1 (2.4)
Primary unknown 1 (2.4)
With lymph node or distant metastasis 35 (85.4)
SD¼ standard deviation.2.2. Treatment regimen and protocol
Dang Gui Liu Huang Tang is a traditional therapy comprising
drugs prepared from seven medicinal plants: Dang Gui (Radix
Angelicae sinensis), Sheng Di Huang (Epimedium sagittatum), Shu
Di Huang (E. sagittatum), Huang Qin (Radix Scutellariae baica-
lensis), Huang Lian (Rhizoma Coptidis), Huang Bai (Cortex Phello-
dendri), and Huang Qi (Radix Astragali). In our study, we modiﬁed
Dang Gui Liu Huang Tang by adding two further herbal drugs that
are widely used to treat sweating: Fu Xiao Mai (Tritici levis
fructus) and Mu Li (Ostreae concha). The daily dose of the
modiﬁed Dang Gui Liu Huang Tang was 9.0 g Dang Gui, 15.0 g
Sheng Di Huang, 12.0 g Shu Di Huang, 9.0 g Huang Qin, 8.0 g
Huang Lian, 8.0 g Huang Bai, 15.0 g Huang Qi, 11.25 g Fu Xiao Mai,
and 15.0 g Mu Li. The herbs were chopped, and their extracts
were obtained twice a day using 1000 mL of boiling water until
200 mL of liquid remained in the container. Each 200 mL herb
concentrate was administered to the enrolled patients after
breakfast and dinner for 10 consecutive days; a 1-hour interval
was followed between the administration of the extracts and that
of other drugs. We attempted to complete the entire course of
this herbal regimen; however, the treatment was discontinued in
cases where allergy, bowel obstruction, disturbance to con-
sciousness, or death rattle developed.2.3. Quantitative assessment of sleep sweats
Sweating was measured using a paper tissue absorption
method. Twice each daydat 9:00 AM and 9:00 PMd10 layers of cut
paper tissues (2 cm  2 cm) were placed over an area of smooth
skin on the right side of the neck (at the midpoint of the sterno-
cleidomastoid muscle) and tightly covered using a 6 cm  7-cm
Tegaderm dressing (3M Health Care Co., Minneapolis, MN, USA).
The change in the weight of the paper tissue was calculated
immediately after its removal; the same well-trained physician’s
assistant both applied and removed the tissue. This evaluation was
performed daily, starting on the day before treatment initiation,
until the 10th day of treatment.
2.4. Subjective estimation of sweating
The overall change in sweating symptoms was estimated by the
patients and their caregivers using a visual analog scale (VAS) that
ranged from 0 to 10.
2.5. Safety assessment
Safety evaluations were graded according to Version 2 of the
Common Toxicity Criteria, published by the National Cancer Insti-
tute in 19986.
2.6. Data analysis
Data were expressed as mean± standard error. Repeated mea-
sures analysis of variance was used to compare the amount of
sweating with the subjective estimation of sweating over time.
Statistical analyses were performed using the SPSS software pack-
age Version 18.0 (SPSS Inc., Chicago, IL, USA), and p< 0.05 was
considered signiﬁcant.
3. Results
The characteristics of the 41 patients are presented in Table 1. In
summary, the mean age of the study participants was 69.0± 6.4
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patients had lymph node or distance metastasis.
The quantitative measurement revealed that sweating had
completely resolved either during or after treatment in 29 of the 41
patients (70.7%). As shown in Figure 1, the mean sweating volume
had decreased signiﬁcantly over time (p< 0.05). The average time
required to achieve a 50% decrease in sweating was 5.3 days.
In the 10 point VAS sweating score estimated by the patients
and their caregivers, the mean decreases were 7.6 and 8.0,
respectively. Figure 2 shows the changes in the VAS scores esti-
mated by patients, while Figure 3 shows those estimated by their
caregivers. On a different note, 78.0% of patients experienced an
increase in appetite after the treatment.
The most common treatment-related adverse events were
diarrhea (14.6%), nausea (12.1%), and allergy (2.4%); their severity
was never greater than Grade 2. Furthermore, these complications
resolved after cessation of treatment, and all 41 of the patients
completed the study.Figure 2. A visual analog scale sweating score was estimated by the patients. Data are
expressed as mean ± standard error.4. Discussion
In TCM, sleep sweats are both a symptom and a sign; they are
characterized by sweating that develops while sleeping and stops
after waking. In contrast, idiopathic sweating can develop at any
time. Sleep sweats of unknown cause are a common symptom in
patients with terminal cancer, comprising those sleep sweats that
occur despite any underlying diseases and possible etiologies (in-
fections, hypoglycemia, and use of drugs that may affect the
sweating temperature threshold) being eliminated. They are not
inherently life-threatening, but the resultant lack of sleep can cause
further anxiety, as well as an increased risk of upper respiratory
tract infections7. To date, no appropriate treatment for sleep sweats
of unknown cause has been found.
Several pharmacological investigations have reported drugs that
can affect the sweating temperature threshold. For example, oral
contraceptive hormones cause this threshold to increase8.
Conversely, the nitric oxide inhibitor NG-nitro-L-arginine methyl
ester (L-NAME)reduces sweating in horses during exercise9,
possibly because nitric oxide regulates cutaneous vasodilatation
and thermoregulation10e12. It has also been reported that clonidine
increases the sweating temperature threshold13e15, whereas theFigure 1. The amount of sweating was measured using a paper tissue absorption
method. Data were collected from 41 individuals and expressed as mean± standard
error.
Figure 3. A visual analog scale sweating score was estimated by the caregivers. Data
are expressed as mean± standard error.narcotic analgesic tramadol decreases the threshold and has a
slight thermoregulatory effect16. Nonetheless, in current palliative
medicine, sleep sweats of unknown cause have no documented,
effective treatment.
Dang Gui Liu Huang Tang is an herbal therapy commonly used in
TCM to treat sleep sweats. The ingredients of the Dang Gui Liu
Huang Tang used in this study were identical to those described in
the Lan Shi Mi Chang (also known as the Secret Treasure of the
Orchid Chamber)dan ancient medical book written by Li17. On the
basis of previous clinical observations, we added two herbal drugs
to the decoction, producing a modiﬁed prescription18. We then
evaluated this medication’s effectiveness. We found that the
modiﬁed Dang Gui Liu Huang Tang was effective in treating pa-
tients with terminal cancer who had unexpected sweating, and that
the treatment led to no signiﬁcant adverse reactions. Furthermore,
the increased appetite that occurred after administration of the
modiﬁed Dang Gui Liu Huang Tang suggests that it promotes gen-
eral well-being and quality of life in patients with cancer. None-
theless, we could not determinewhether themodiﬁed Dang Gui Liu
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did not compare the two prescriptions in this study.
In TCM, Dang Gui Liu Huang Tang is administered to people with
a generalized “Yin” deﬁciency. In modern medicine, the mixture
may help improve general well-being and restore normal physical
energy and function. Herbal therapists who are practitioners of
TCM prescribe herbal remedies on the basis of individual physical
conditions (e.g., body constitution or syndromes) after assessing
patients on the basis of unique diagnostic systems. In this study, we
administered a modiﬁed Dang Gui Liu Huang Tang to patients with
sleep sweats. This strategy is not identical to that used in TCM;
however, an herbal therapist working at the hospice ward exam-
ined all of the enrolled patients and found that 73.1% of the patients
had a “Yin” deﬁciency syndrome according to TCM.
The results of this study indicate that modiﬁed Dang Gui Liu
Huang Tang relieves sleep sweats of unknown cause in patients
with terminal cancer, and that it increases appetite in those pa-
tients; the treatment is without any signiﬁcant complications.
Because this study was a nonrandomized trial, most of the enrolled
participants were elderly patients. We therefore could not deter-
mine whether the modiﬁed Dang Gui Liu Huang Tang was more
beneﬁcial in patients of a particular age, or indeed if it was only
effective in elderly patients. In future, randomized, double-blinded
clinical trials arewarranted to conﬁrm the therapeutic effects of the
treatment.
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